Revenue | ₹0.05Cr |
Net Profits | ₹0.43Cr |
Net Profit Margins | -860.00% |
Transgene Biotek Ltd’s revenue fell -92.86% since last year same period to ₹0.05Cr in the Q1 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated -58.33% fall in its revenue since last 3-months.
Transgene Biotek Ltd’s net profit fell -315% since last year same period to ₹0.43Cr in the Q1 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 39.44% jump in its net profits since last 3-months.
Transgene Biotek Ltd’s net profit margin fell -3110% since last year same period to -860.00% in the Q1 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated -45.35% fall in its net profit margins since last 3-months.
The revenue for Transgene Biotek Ltd in the Q1 results 2025 was ₹0.05Cr.
The net profit for Transgene Biotek Ltd in the Q1 results 2025 was ₹0.43Cr.
The net profit margin for Transgene Biotek Ltd in the Q1 results 2025 was -860.00%.
The revenue for Transgene Biotek Ltd in the Q1 results 2024 was ₹0.70Cr.
The net profit for Transgene Biotek Ltd in the Q1 results 2024 was ₹0.20Cr.
The net profit margin for Transgene Biotek Ltd in the Q1 results 2024 was 28.57%.